Salospir - 33 years at patient's health service

With the award of "Centenarian brand 2019" for the product Salospir, for its 33 years of presence in the pharmaceutical market, Uni-pharma Pharmaceutical Industry was awarded on 26/6/2019.

The award was received by the Marketing Manager of Uni-pharma SA pharmacist Mr. Markos Theodorou.

SALOSPIR is a product of independent research and know-how of the Uni-Pharma Pharmaceutical Industry since 1986, when it was first released. It has as active ingredient acetylsalicylic acid in the form of enteric-coated tablets, so as to protect the stomach from the irritant effects of acetylsalicylic acid.

It is a product, which effect has been proven through clinical studies, that can provide the necessary preventative treatment as anticoagulant and platelet antiplatelet. which in simple terms means prevention of myocardial infarction both preoperatively and postoperatively.

Salossir, in 2018, sold 10 million units, only in Greece, with growth over 3% over the previous year. It is also worth noting that in 2018 over 550,000 Greeks were in daily treatment with SALOSPIR for the whole year.

Uni-pharma is the first pharmaceutical company in Greece, which in 1996 has made a major investment to introduce environment-friendly technology by purchasing new technological equipment specifically for the coating of SALOSPIR enteric coated tablets, for which it was honored by the Ministry of Pharmaceutical Industry with the award of the 3rd Prize for "Environmentally Friendly Production Methods and Products".

Salospir was also distinguished in 2003 by the EMEA, with the "2003 Named Product Award".

To provide you with a better browsing experience, our website uses cookies.